Jinquan Cai
Harbin, 150086, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Retraction: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: March 17, 2026
Immunotherapeutic strategies targeting the PVR-TIGIT/CD96/CD226 signaling pathway in glioma treatment.
Journal: Annals of medicine
Published: November 19, 2025
Updated clinical practice guidelines for the management of adult diffuse gliomas.
Journal: Cancer letters
Published: September 03, 2025
Mitoxantrone alters CD24/Siglec-10 expression in malignant brain tumor models.
Journal: Scientific reports
Published: February 13, 2025
Editorial: Insights and implications of mechanisms shaping glioma immune landscape, immunotherapy resistance, and relevant translational research.
Journal: Frontiers in oncology
Published: August 24, 2024
LncRNA-Mediated TPI1 and PKM2 Promote Self-Renewal and Chemoresistance in GBM.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 12, 2024
RETRACTED: Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 18, 2023
Development and validation of a pyroptosis-related genes signature for risk stratification in gliomas.
Journal: Frontiers in genetics
Published: November 08, 2022
Association of Personality Traits with Life and Work of Medical Students: An Integrative Review.
Journal: International journal of environmental research and public health
Published: August 03, 2022
Last Updated: 09/26/2026